| Expression System | CHO |
|---|
| Protein Tag | C-His |
|---|
| Purity | > 95% by SDS-PAGE under reducing conditions |
|---|
| Endotoxin | < 1 EU per ug by the LAL method |
|---|
| Activity | Positive |
|---|
| Conjugate | Unconjugated |
|---|
| Species | Human |
|---|
| Accession Number | AAA35907.1 |
|---|
| Protein Sequence | Ser32-Ile193 |
|---|
| Molecular Weight | The recombinant human GM2A has the predicted molecular weight of 18.9 kD. The DTT-reduced protein migrates at approximately 20 kD on SDS-PAGE |
|---|
| Formulation | PBS, pH 7.4 with 300mM NaCl (0.2 μm filtered) |
|---|
| Concentration | 25µg size is bottled at 0.2mg/mL concentration. 100 µg and 500 µg size is bottled at lot specific concentration. |
|---|
| Purification | Affinity Ni-NTA |
|---|
| Applications | ELISA |
|---|
| Format | Liquid |
|---|
| Reconstitution | NA |
|---|
| Shipping Condition | Cold Pack |
|---|
| Storage/Shelf Life | An unopened vial can be stored at 4°C for 2 weeks or at -20°C and below for six months. This stock solution should be aliquoted and stored at -70°C to minimize the freeze/thaw cycles. |
|---|
| Background Information | The human GM2A protein, also known as the ganglioside GM2 activator, is a small lipid transfer protein that acts as a cofactor for the lysosomal enzyme beta-hexosaminidase A. It plays a crucial role in the degradation of GM2 gangliosides and other molecules with terminal N-acetyl hexosamines. |
|---|
| figure legend1 | Purified GM2A-FLAG on SDS-PAGE under non-reducing (P-) and reducing (P+) conditions. The purity of GM2A-FLAG is greater than 95%. |
|---|
| country of manufacture | USA |
|---|
| HazMat y/n | N |
|---|
